ACO Participants

  • Brackenrich Family Practice PLC
  • Casey Health Institute Inc
  • Dunkirk Family Practice PA
  • Gerald Dimaso MDPC
  • Green Spring Internal Medicine, LLC
  • Jesse Sadikman, MD, LLC
  • Jonathan Bremer
  • South Shore Physicians
  • Vivian Clark
  • Western Maryland Health Care Corporation
  • WVVA Health Care Alliance PC

No participants are involved in a joint venture between ACO professionals and hospitals

ACO Governing Body

  • Dr. Holly Dahlman, Voting Member, Green Spring Internal Medicine, LLC
  • Dr. Shawn Long, Voting Member, Western Maryland Health Care Corporation
  • Dr. Jesse Sadikman, Voting Member, Jesse Sadikman, MD, LLC
  • Dr. David Fogel, Voting Member, Casey Health Institute Inc
  • Dr. Amy Goff, Voting Member, WVVA Health Care Alliance PC
  • Nadine Brackenrich, Voting Member, Brackenrich Family Practice PLC
  • Dr. Joyce Owens, Voting Member, Dunkirk Family Practice PA
  • Dr. Gerald DiMaso, Voting Member, Gerald DiMaso MDPC
  • Dr. Paul Gazzara, Voting Member, South Shore Physicians
  • Dr. Jonathan Bremer, Voting Member, Jonathan Bremer
  • Dr. Vivian Clark, , Voting Member, Vivian Clark
  • Dan Bowles, Chair and Voting Member, Aledade, Inc.

Key Clinical and Administrative Leadership

  • Executive Director: Mr. Dan Bowles
  • Medical Director: Dr. Jesse Sadikman
  • Compliance Officer: Mr. Brian Lynch

ACO Committees and Committee Leaderships

  • Beneficiary Engagement Committee: Dr. David Krasner, Chair
  • Compliance Committee: Dr. Sal Volpe, Chair
  • Transitions of Care Committee: Dr. Rebecca Jaffe, Chair
  • Evidence-Based Medicine Committee: Dr. Charles Stanislav, Co-Chair and Dr. Holly Dahlman, Co-Chair
  • Performance Improvement Committee: Dr. Sarah Mullins, Co-Chair and Dr. Beshara Helou, Co-Chair

Composition of ACO

  • A network of individual practices of ACO professionals

Amount of Shared Savings/Losses

  • Agreement period beginning 2015: Performance Year 2015: $0

How Shared Savings Are Distributed

Agreement period beginning 2015, Performance Year 2015

10%

Reinvest in infrastructure

30%

Invested in redesigned care processes/resources

60%

Distribution to ACO Participants

100%

Primary Care Professionals

N/A

Specialists

N/A

Hospital

Payment Rule Waivers

  • No, our ACO does not utilize the SNF 3-Day Rule Waiver

Quality Reporting

Measure NumberMeasure Name2015 Reporting Period
ACO Performance RateMean performance rate (SSP- ACOs)
ACO-1CAHPS: Getting Timely Care, Appointments, and Information 82.0680.61
ACO-2CAHPS: How Well Your Providers Communicate93.0092.65
ACO-3CAHPS: Patients’ Rating of Provider92.4391.94
ACO-4CAHPS: Access to Specialists82.6183.61
ACO-5CAHPS: Health Promotion and Education58.0759.06
ACO-6CAHPS: Shared Decision Making77.0775.17
ACO-7CAHPS: Health Status/Functional Status71.0372.30
ACO-34CAHPS: Stewardship of Patient Resources*29.9626.87
ACO-8Risk Standardized, All Condition Readmission14.2514.86
ACO-35Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)*18.0718.07
ACO-36All-Cause Unplanned Admissions for Patients with Diabetes*41.9854.60
ACO-37All-Cause Unplanned Admissions for Patients with Heart Failure*68.1876.96
ACO-38All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions54.0462.92
ACO-9Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)1.151.11
ACO-10Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8)0.921.04
ACO-11Percent of PCPs who Successfully Meet Meaningful Use Requirements96.77%76.22%
ACO-39Documentation of Current Medications in the Medical Record*99.01%84.07%
ACO-13Falls: Screening for Future Fall Risk34.55%56.46%
ACO-14Preventive Care and Screening: Influenza Immunization74.05%62.03%
ACO-15Pneumonia Vaccination Status for Older Adults74.12%63.73%
ACO-16Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up82.11%71.15%
ACO-17Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention91.94%90.16%
ACO-18Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan40.97%45.25%
ACO-19Colorectal Cancer Screening59.13%60.06%
ACO-20Breast Cancer Screening71.03%65.67%
ACO-21Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented92.28%70.04%
ACO-40Depression Remission at Twelve Months*N/AN/A
ACO-27Diabetes Mellitus: Hemoglobin A1c Poor Control26.39%20.38%
ACO-41Diabetes: Eye Exam*40.28%41.05%
ACO-28Hypertension: Controlling High Blood Pressure64.66%69.62%
ACO-30Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic85.49%83.82%
ACO-31Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)82.00%87.22%
ACO-33Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)76.10%77.73%
CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease.
*= Measure required beginning Reporting Year 2015.
N/A= Reporting on the depression remission measure is not required for 2015, as indicated by N/A